Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of preventing and treating type 1 diabetes, allograft rejection and lung fibrosis (by targeting the ATP/P2X7R axis)

Method of preventing and treating type 1 diabetes, allograft rejection and lung fibrosis (by targeting the ATP/P2X7R axis)

US Patent 11452781 · Granted Sep 27, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies and uses thereof2025
TMEM219 antibodies and therapeutic uses thereof2025
Prevention and treatment of diabetic nephropathy2024
Prevention and treatment of diabetic nephropathy2024
Treatment of type 1 diabetes and autoimmune diseases or disorders2024
PD-L1 expressing hematopoietic stem cells and uses2023
Prevention and treatment of diabetic nephropathy2022
Prevention and treatment of diabetic nephropathy2022
Inhibitor of IGFBP3/TMEM219 axis and diabetes2021
PD-L1 expressing hematopoietic stem cells and uses2020
Inhibitors of IGFBP3 binding to TMEM219 for treatment of intestinal diseases2020
PD-L1 expressing hematopoietic stem cells and uses2019